In the article entitled, “Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells” (Volume 187, pages 214–224 of the January 2017 issue of The American Journal of Pathology; https://doi.org/10.1016/j.ajpath.2016.09.010), the authors have noted that the current support footnote is incomplete as printed and should be updated to read: Supported by NIH grants P01 HL060678, R01 HL045638, P01 HL077806, R01 HL090152, R01 HL118068, and R01 HL125350 (A.B.M.), NIH grant R56 HL128342 (K.H.Y.), American Heart Association grant 13SDG14680053 (K.H.Y.), and a Stein Innovation Award from Research to Prevent Blindness (A.B.M.).
. 2018 Aug;188(8):1934. doi: 10.1016/j.ajpath.2018.06.002
Correction
© 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
PMCID: PMC6593237 PMID: 30033031
This corrects the article "Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells" in volume 187 on page 214.
